Avid Bioservices, Inc. (CDMO)


+0.16 (+0.89%)
Symbol CDMO
Price $18.11
Beta 1.767
Volume Avg. 0.59M
Market Cap 1.133B
Shares () -
52 Week Range 11.3-22.38
1y Target Est -
DCF Unlevered CDMO DCF ->
DCF Levered CDMO LDCF ->
ROE 64.69% Strong Buy
ROA 25.86% Buy
Operating Margin -
Debt / Equity 142.96% Buy
P/E 11.54 Strong Buy
P/B 6.09 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest CDMO news

Mr. Nicholas Stewart Green B.Sc., MBA
NASDAQ Capital Market

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.